Clinical Trial Update: A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 pilot trial of Exendin-4 in Alzheimer's disease and mild cognitive impairment was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Exendin-4 (exendin-4)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Status: TERMINATED | Results posted: 2018-02-22